Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cellnovo

Market Cap 2.44M 2.11M 1.95M 1.83M 3.41M 233M 3.48M 23.24M 9M 112M 9.14M 8.95M 391M P/E Ratio 2018 *
-0.15x
P/E Ratio 2019 * -
Enterprise Value 12.46M 10.81M 9.97M 9.34M 17.45M 1.19B 17.81M 119M 46.02M 575M 46.77M 45.76M 2B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-1.78%-9.55%-37.23%-49.07% 8.83B
-0.89%-7.17%+37.64%+18.44% 6.61B
+2.21%+0.55%-32.06%+234.05% 3.62B
+2.25%-5.34%-34.97%-48.33% 2.06B
+0.83%-1.88%-36.35%-46.88% 1.88B
+1.31%+1.46%-1.87%+42.88% 1.69B
+1.61%-3.00%+14.71%+97.50% 1.56B
+2.37%-0.11%-43.08%-54.57% 1.11B
+1.53%+6.05%-10.24%+81.49% 1.09B
Average +0.87%-2.48%-15.94%+30.61% 2.85B
Weighted average by Cap. +0.02%-5.77%-13.22%+21.10%

Financials

2018 2019 *
Net sales 3.32M 2.88M 2.66M 2.49M 4.65M 318M 4.75M 31.7M 12.27M 153M 12.47M 12.2M 533M -
Net income -15.94M -13.83M -12.75M -11.95M -22.32M -1.53B -22.79M -152M -58.89M -736M -59.84M -58.55M -2.56B -
Net Debt 10.02M 8.7M 8.02M 7.51M 14.04M 960M 14.33M 95.63M 37.03M 463M 37.62M 36.81M 1.61B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!